Subscribe to InsuranceERM to benefit from:
- In-depth special reports and analysis
- Commentary and insight from leading industry specialists
- Discounts for InsuranceERM events
© Field Gibson Media Ltd 2022Subscribe now
Note highlights premium and claims issues in case of Euro fall-out
The LLMA's new indices promise a more tradable market in longevity risk, with greater appeal to investors, according to market players. But the market remains stuck in a "chicken and egg" situation on liquidity. Lorna Davies reports
Four indices will be launched on Bloomberg platform later this year
Aegon's €12bn longevity swap last month appeared to be the deal that would finally kick-start the heavily-hyped longevity risk transfer business. But the finer details reveal more marketing spin than substance. Sarfraz Thind investigates
Rupert Atkin will take up role in February
There are lots of obstacles to developing a market in longevity. Despite a few significant deals, there's "not an avalanche of interest" one expert says. Lorna Davies sounds out opinion.
A delay to Solvency II appears inevitable, but there are competing views as to how this should be achieved. Michael Faulkner reports on the implications of a postponement.
LLMA plans to launch own mortality index
Aviva has joined the Life & Longevity Markets Association, bringing the LLMA's membership to eleven.
Proposed UK financial services regulatory system too banking-focused